Physiological Role of Plasmacytoid Dendritic Cells and Their Potential Use in Cancer Immunity
2008
Role of Plasmacytoid Dendritic Cells in Cancer Immunity
publication
Evidence: moderate
Author Information
Author(s): Jorge Schettini, Pinku Mukherjee
Hypothesis
Plasmacytoid dendritic cells (pDCs) can be targeted for therapeutic manipulations to enhance immune responses against tumors.
Conclusion
Plasmacytoid dendritic cells are crucial in regulating immune responses and can be manipulated to improve cancer immunotherapy.
Supporting Evidence
- pDCs can produce high levels of type I interferons, which are important for immune responses.
- pDCs have been found in various tumors, suggesting their role in cancer immunity.
- Therapeutic strategies targeting pDCs may enhance the effectiveness of cancer vaccines.
Takeaway
Plasmacytoid dendritic cells help our body fight cancer by producing special signals that boost the immune system.
Methodology
The review discusses the characteristics, physiology, and potential roles of pDCs in immune responses and cancer.
Limitations
The understanding of human pDCs is less comprehensive compared to mouse models, and the review is based on existing literature rather than original research.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website